A Randomized Controlled Trial of an Implantable 2-Channel Peroneal Nerve Stimulator on Walking Speed and Activity in Poststroke Hemiplegia

Kottink AI, Hermens HJ, Nene AV, Tenniglo MJ, van der Aa HE, Buschman HP, IJzerman MJ. A randomized controlled trial of an implantable 2-channel peroneal nerve stimulator on walking speed and activity in poststroke hemiplegia. To determine the effect of a new implantable 2-channel peroneal nerve sti...

Full description

Saved in:
Bibliographic Details
Published inArchives of physical medicine and rehabilitation Vol. 88; no. 8; pp. 971 - 978
Main Authors Kottink, Anke I., Hermens, Hermie J., Nene, Anand V., Tenniglo, Martin J., van der Aa, Hans E., Buschman, Hendrik P., IJzerman, Maarten J.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.08.2007
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Kottink AI, Hermens HJ, Nene AV, Tenniglo MJ, van der Aa HE, Buschman HP, IJzerman MJ. A randomized controlled trial of an implantable 2-channel peroneal nerve stimulator on walking speed and activity in poststroke hemiplegia. To determine the effect of a new implantable 2-channel peroneal nerve stimulator on walking speed and daily activities, in comparison with the usual treatment in chronic stroke survivors with a drop foot. Randomized controlled trial. All subjects were measured 5 times in the gait laboratory. Twenty-nine stroke survivors with chronic hemiplegia with drop foot who fulfill the predefined inclusion and exclusion criteria were included in the study. The intervention group received an implantable 2-channel peroneal nerve stimulator for correction of their drop foot. The control group continued using their conventional walking device, consisting of an ankle-foot orthosis, orthopedic shoes, or no device. Walking speed, assessed both by a six-minute walk test (6MWT) and by using a 10-m walkway, was selected as primary outcome measure and activity monitoring data, consisting of percentage time spent on stepping, standing, and sitting/lying were selected as secondary outcome measure. Functional electric stimulation (FES) resulted in a 23% improvement of walking speed measured with the 6MWT, whereas the improvement in the control group was only 3% ( P=.010). Comfortable walking speed measured on a 10-m walkway was also significantly improved in favor of FES ( P=.038). The percentage time spent on stepping deteriorated with 3% in the intervention and 0.8% in control group, which was not statistically significant between both groups ( P=.13). The present study shows a clinically relevant effect of the implantable 2-channel peroneal nerve stimulator on walking speed in the sample of stroke survivors included in our study.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0003-9993
1532-821X
DOI:10.1016/j.apmr.2007.05.002